‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism

Objective We sought to understand the factors that influence a general practitioner’s (GP’s) experience of screening for primary aldosteronism (PA) in hypertensive patients.Design A qualitative study, framed by phenomenology, using semistructured interviews that were audiorecorded, transcribed verba...

Full description

Saved in:
Bibliographic Details
Main Authors: Sanne Peters, Jun Yang, Grant Russell, Abhir Krishan Nainani
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/6/e061671.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583819891310592
author Sanne Peters
Jun Yang
Grant Russell
Abhir Krishan Nainani
author_facet Sanne Peters
Jun Yang
Grant Russell
Abhir Krishan Nainani
author_sort Sanne Peters
collection DOAJ
description Objective We sought to understand the factors that influence a general practitioner’s (GP’s) experience of screening for primary aldosteronism (PA) in hypertensive patients.Design A qualitative study, framed by phenomenology, using semistructured interviews that were audiorecorded, transcribed verbatim, entered into NVivo V.12.0 for coding and analysed for emerging themes.Setting Melbourne, Australia.Participants Eligible GPs had received education on PA as part of a previous study. We recruited a purposive sample of 16 GPs (6 females, 10 males) who varied in practice location, clinical experience and the number of patients screened for PA.Results Although GPs had been educated about PA, they found it challenging to explain the condition to patients and were uncertain about how to screen patients who were already taking antihypertensive medications. Most viewed the screening process to be practical, inexpensive and, by and large, acceptable to their patients. However, they found it inconvenient to alter antihypertensive medications before screening to allow for easier interpretation of the aldosterone-renin ratio. They were also less enthused about screening patients whom they thought fitted a clinical picture of essential hypertension. Knowledge of the screening process, cost and convenience of performing the aldosterone–renin ratio, conceptualisation of risk related to PA, and a desire to improve clinical care were influencing factors that modified the GPs’ screening experience.Conclusion Our findings suggest that knowledge gaps, practical limitations of the aldosterone–renin ratio, and errors in diagnostic reasoning were challenges of routine PA screening. Most of these practical barriers could be addressed by relatively simple educational and practice modifications to increase PA screening rates and optimise detection for the most common cause of secondary hypertension in primary care.
format Article
id doaj-art-e0ef106cd4ea441f90eae34df28f64a0
institution Kabale University
issn 2044-6055
language English
publishDate 2022-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-e0ef106cd4ea441f90eae34df28f64a02025-01-28T06:20:09ZengBMJ Publishing GroupBMJ Open2044-60552022-06-0112610.1136/bmjopen-2022-061671‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronismSanne Peters0Jun Yang1Grant Russell2Abhir Krishan Nainani3School of Health Sciences, The University of Melbourne, Melbourne, Victoria, AustraliaDepartment of Cardiovascular Ultrasound, The First Hospital of China Medical University, Shenyang, China8 Department of General Practice, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, AustraliaDepartment of General Practice, Monash University, Clayton, Victoria, AustraliaObjective We sought to understand the factors that influence a general practitioner’s (GP’s) experience of screening for primary aldosteronism (PA) in hypertensive patients.Design A qualitative study, framed by phenomenology, using semistructured interviews that were audiorecorded, transcribed verbatim, entered into NVivo V.12.0 for coding and analysed for emerging themes.Setting Melbourne, Australia.Participants Eligible GPs had received education on PA as part of a previous study. We recruited a purposive sample of 16 GPs (6 females, 10 males) who varied in practice location, clinical experience and the number of patients screened for PA.Results Although GPs had been educated about PA, they found it challenging to explain the condition to patients and were uncertain about how to screen patients who were already taking antihypertensive medications. Most viewed the screening process to be practical, inexpensive and, by and large, acceptable to their patients. However, they found it inconvenient to alter antihypertensive medications before screening to allow for easier interpretation of the aldosterone-renin ratio. They were also less enthused about screening patients whom they thought fitted a clinical picture of essential hypertension. Knowledge of the screening process, cost and convenience of performing the aldosterone–renin ratio, conceptualisation of risk related to PA, and a desire to improve clinical care were influencing factors that modified the GPs’ screening experience.Conclusion Our findings suggest that knowledge gaps, practical limitations of the aldosterone–renin ratio, and errors in diagnostic reasoning were challenges of routine PA screening. Most of these practical barriers could be addressed by relatively simple educational and practice modifications to increase PA screening rates and optimise detection for the most common cause of secondary hypertension in primary care.https://bmjopen.bmj.com/content/12/6/e061671.full
spellingShingle Sanne Peters
Jun Yang
Grant Russell
Abhir Krishan Nainani
‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism
BMJ Open
title ‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism
title_full ‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism
title_fullStr ‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism
title_full_unstemmed ‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism
title_short ‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism
title_sort i can t understand why others don t screen more a qualitative study exploring why australian general practitioners screen for primary aldosteronism
url https://bmjopen.bmj.com/content/12/6/e061671.full
work_keys_str_mv AT sannepeters icantunderstandwhyothersdontscreenmoreaqualitativestudyexploringwhyaustraliangeneralpractitionersscreenforprimaryaldosteronism
AT junyang icantunderstandwhyothersdontscreenmoreaqualitativestudyexploringwhyaustraliangeneralpractitionersscreenforprimaryaldosteronism
AT grantrussell icantunderstandwhyothersdontscreenmoreaqualitativestudyexploringwhyaustraliangeneralpractitionersscreenforprimaryaldosteronism
AT abhirkrishannainani icantunderstandwhyothersdontscreenmoreaqualitativestudyexploringwhyaustraliangeneralpractitionersscreenforprimaryaldosteronism